The Ohio State University

education 📍 Columbus, United States
The Ohio State University
2
EM Publications
2
EM Researchers

Associated Institutions

Nationwide Children's Hospital
related
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
related
The Ohio State University at Mansfield
child
The Ohio State University at Marion
child
The Ohio State University at Lima
child

Publications

Life-threatening hypothermia in a child with primary erythromelalgia.

Matarneh B, Witman P
Pediatric dermatology

Primary erythromelalgia is a rare autosomal-dominant condition due to pathogenic variant in the SCN9A gene, characterized by childhood onset of excruciating pain, redness, and warmth of acral sites. Patients often resort to ice water baths and other cooling measures to manage the discomfort. Hypothermia is a rare complication, reported only twice previously. We report a child with primary erythromelalgia due to a confirmed pathogenic variant admitted with life-threatening hypothermia. Although the overuse of cooling mechanisms may have contributed, we postulate that the SCN9A mutation may lead to thermodysregulation and make patients with primary erythromelalgia particularly susceptible to this complication.

Erythromelalgia in the pediatric patient: role of computed-tomography-guided lumbar sympathetic blockade.

Kundu A, Rafiq M, Warren PS, Tobias JD
Journal of pain research

Erythromelalgia (EM) is an uncommon condition characterized by erythema, increased skin temperature, and burning pain, most frequently occurring in the lower extremities. The pain is generally very severe and treatment can be extremely challenging, especially in the pediatric and adolescent population. We report a series of three cases of primary EM in pediatric patients involving the lower extremities, refractory to medical treatment that responded favorably to computed-tomography-guided lumbar sympathetic blockade. There was a significant improvement in pain scores, quality of life, and overall function as well as decreased analgesic requirements. Lumbar sympathetic blockade should be considered as a therapeutic modality in pediatric and adolescent patients with EM who are refractory to other treatments.